Bayer is a German multinational pharmaceutical and life sciences company and one of the largest pharmaceutical companies in the world. Headquartered in Leverkusen, Bayer's areas of business include human and veterinary pharmaceuticals; consumer healthcare products; agricultural chemicals, seeds and biotechnology products.
P/E
Net profit
P/B
Book value
P/FCF
FCF
Yield
Growth potential
Bayer news
30.06.2022
Bayer has received approval from the Chinese Medicines Administration for Kerendia. The drug is intended for the treatment of chronic kidney disease associated with type 2 diabetes in adults.
Source: 
media.bayer.de
media.bayer.de
10.05.2022
Bayer's IFRS net income for 3 months of 2022 was €3.291 billion, up 57.5% from €2.089 billion in the previous year. Revenue rose 18.7% to €14.639 billion compared with €12.328 billion a year earlier.
Source: 
media.bayer.com
media.bayer.com
28.03.2022
Bayer has received approval from the Japanese Ministry of Health, Labor and Welfare to sell the drug finerenone under the brand name Kerendia. The drug is intended to treat chronic kidney disease and type 2 diabetes. Finerenone was previously approved for sale in the EU and the US.
Source: media.bayer.de
media.bayer.de
10.03.2022
Bayer is selling its Environmental Science business, which produces pest and disease control substances for non-agricultural plants, to Cinven. Cinven will pay €2.4 billion. The deal is scheduled to close in the 2nd half of 2022.
Source: media.bayer.de
media.bayer.de
General information
| Company name | Bayer |
|---|---|
| Tags | #pharmacy, #dax index |
| Sector | Health Care / Pharmaceuticals, Biotechnology & Life Sciences / Pharmaceuticals / Pharmaceuticals |
| Business address | 51368 Leverkusen Germany |
| Website | www.bayer.com |
English (US) 